COR Q2 2023 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q2 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$63.5B+9.9% YoY

Gross Profit

$2.1B3.2% margin

Operating Income

$733M1.2% margin

Net Income

$435M0.7% margin

EPS (Diluted)

$2.13

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$630M

Free Cash Flow

$527M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$58.8B

Total Liabilities

$58.3B

Stockholders' Equity

$282M

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63.5B	$57.7B	+9.9%
Gross Profit	$2.1B	$2.1B	-0.3%
Operating Income	$733M	$857M	-14.4%
Net Income	$435M	$548M	-20.5%

Revenue Segments

Pharmaceutical Distribution

$55.5B87%

International Healthcare Solutions

$6.8B11%

Animal Health

$1.2B2%

Geographic Segments

U.S. Healthcare Solutions

$56.7B89%

International Healthcare Solutions

$6.8B11%